A bullish thesis on Linde plc (LIN), published on Astute Optics’ Substack, makes a case worth examining—not because industrial gases are novel as an investment theme, but because the sector’s economics are frequently misunderstood by investors who treat these companies as commodity chemical producers rather than what they actually are: infrastructure businesses with contractual revenue visibility.
The numbers frame the debate. LIN traded at $510.36 as of October 22, 2026, carrying a trailing P/E of 29.99 and a forward multiple of 23.58 according to Yahoo Finance. That compression from trailing to forward earnings implies the market expects meaningful earnings growth—roughly 25% on a multiple basis—which is a real claim to underwrite, not a rounding error.
The core of the bull case rests on contract structure and pricing power, and here the thesis is on solid ground. Industrial gases—oxygen, nitrogen, argon, hydrogen—are largely sold under long-term take-or-pay style contracts, typically 15 to 20 years, with on-site generation facilities built against committed customer demand. The capital expenditure is deployed only after a contract is signed, which inverts the usual risk profile of infrastructure investing: utilization risk is largely transferred to the customer before the first dollar of capex is committed. Contract escalators, often indexed to energy and input costs, pass through a substantial portion of commodity volatility. This is why Linde and Air Products have historically defended margins through cycles that crushed other industrials.
The demand side of the thesis is more interesting than the supply economics. Electronics manufacturing—semiconductor fabs require ultra-high-purity nitrogen at enormous scale—is driving a genuine, funded wave of gas demand tied to onshoring commitments in the United States and Asia. Hydrogen for refining and emerging clean-energy applications, and gases for space and healthcare end markets, add further secular legs. But investors should apply the usual discipline: announced fab construction and announced hydrogen projects are not the same as operational capacity. Linde’s backlog converts to revenue only as projects complete and contracts commence, and execution timelines in this sector have lengthened alongside everything else in energy infrastructure.
The comparison embedded in the source headline—LIN versus Air Products and Dow—highlights the strategic divergence within the sector. Air Products has pursued an aggressive, capital-intensive clean hydrogen strategy with multibillion-dollar projects carrying execution and offtake risk, while Linde has generally stuck to its disciplined model of contracted, de-risked capacity additions. Dow, as a commodity chemicals producer, lacks the contractual architecture entirely and remains exposed to petrochemical spreads. These are fundamentally different business models wearing similar sector labels, and the valuation gap between them reflects, at least in part, rational differences in risk.
The skeptics’ case deserves airing. A near-30x trailing multiple for an industrial is rich, and it leaves little room for demand disappointment or capex missteps. Linde’s scale means growth increasingly depends on mega-project execution, where cost overruns are the norm rather than the exception. And the hydrogen optionality embedded in the stock’s valuation is partly narrative; the addressed market remains substantially policy-dependent, and policy is not a contract.
Still, the bull thesis is not asking investors to believe in anything speculative. It asks them to pay up for contracted, inflation-protected infrastructure cash flows attached to genuine industrial demand—which is precisely what Linde sells. At 23.6x forward earnings, the market is pricing in delivery, not perfection.
The investment implication is straightforward: industrial gases remain one of the few places where energy-adjacent infrastructure offers utility-like revenue quality with industrials-level growth, and the premium multiple is the price of that combination. Whether it’s cheap enough depends entirely on whether the backlog converts on schedule.
